Lenke Molnar
Overview
Explore the profile of Lenke Molnar including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
6
Citations
3
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Szendrei T, Magyarlaki T, Kovacs G, Nagy A, Szomor A, Molnar L, et al.
Orv Hetil
. 2008 Jan;
149(4):161-7.
PMID: 18201958
Introduction: New prognostic factors discovered in chronic lymphocytic leukemia have recently got into the center of clinical interest. While the predictive value of cytogenetical abnormalities, immunoglobulin heavy chain gene mutation...
2.
Jakso P, Kereskai L, Molnar L, Pajor L
Pathol Oncol Res
. 2007 Jul;
13(2):114-22.
PMID: 17607372
In myelodysplastic syndrome (MDS) as well as chronic myeloproliferative disorders (CMPD) others than chronic myeloid leukemia the frequency of pathognomonic genetic aberrations is very low and, therefore, X chromosome inactivation...
3.
Kajtar B, Deak L, Kalasz V, Pajor L, Molnar L, Mehes G
Int J Hematol
. 2005 Nov;
82(4):347-50.
PMID: 16298829
A case of Philadelphia chromosome-positive (Ph(+)) chronic myeloid leukemia (CML) featuring 2 additional balanced translocations, t(2;5) and t(6;12), as well as a robertsonian translocation, t(13;14), was diagnosed by routine bone...
4.
Balog A, Borbenyi Z, Gyulai Z, Molnar L, Mandi Y
Pathobiology
. 2005 Apr;
72(3):165-70.
PMID: 15860935
Objectives: Tumor necrosis factor-alpha (TNF-alpha) and transforming growth factor-beta (TGF-beta) are cytokines that play key roles in the myelodysplastic syndrome (MDS). There have been several reports on the presence of...
5.
Molnar L, Nagy A, David M, Szomor A, Mehes G, Kovacs G, et al.
Orv Hetil
. 2004 Jun;
145(17):901-7.
PMID: 15170967
Background: Chronic myelogenous leukemia is characterised by the presence of Philadelphia translocation and consecutive expression of bcr-abl oncogene with enhanced tyrosine kinase activity, which is known to be the essential...
6.
Molnar L, Losonczy H
Orv Hetil
. 2002 Nov;
143(42):2379-84.
PMID: 12440260
Chronic myeloid leukemia shown to be associated with the Ph translocation,--characterised as a t(9;22)--, joins the bcr and abl genes and leads to expression of chimeric BCR-ABL protein with enhanced...